Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a medical device company headquartered in Irvine, California. It became independent from Baxter International in 2000. Its shares trade on the NYSE under the ticker EW. It is a constituent of the S&P 500 index.

Edwards focuses on the treatment of structural heart disease. Its main products are transcatheter aortic heart valves, which are delivered through a blood vessel without open-heart surgery; the company also offers transcatheter solutions for mitral and tricuspid valve disease, along with surgical heart valves and repair products. The products are used in hospitals by cardiac surgeons and interventional cardiologists, and clinical studies and regulatory approvals play a decisive role in their adoption.

Those following Edwards stock typically watch the pace at which transcatheter valve therapies are adopted, clinical study results for new products and approval and reimbursement decisions by health authorities. On the EW page at Lzzo.com, the share price is shown in US dollars together with a historical price chart and technical indicators.